Acorda Therapeutics (ACOR) Tops Q1 EPS by 1c
Get Alerts ACOR Hot Sheet
Price: $0.66 --0%
EPS Growth %: -139.7%
Financial Fact:
Total net revenues: 135.61M
Today's EPS Names:
SFST, VLTO, CLIR, More
EPS Growth %: -139.7%
Financial Fact:
Total net revenues: 135.61M
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Acorda Therapeutics (NASDAQ: ACOR) reported Q1 EPS of $0.15, $0.01 better than the analyst estimate of $0.14. Revenue for the quarter came in at $99.85 million versus the consensus estimate of $100.2 million.
For earnings history and earnings-related data on Acorda Therapeutics (ACOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SAP Q1 results fall short of Wall Street estimates as transformation kicks off
- NBT Bancorp (NBTB) Reports in-line Q1 EPS
- Brown & Brown (BRO) Tops Q1 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!